We are live on ! Find out more
EC

Euclidean Capital Portfolio holdings

AUM $440M
1-Year Est. Return 28.33%
This Fund
S&P 500
This Quarter Est. Return
+8.69%
1 Year Est. Return
+28.33%
3 Year Est. Return
+79.73%
5 Year Est. Return
-17.94%
10 Year Est. Return
–
AUM
$780M
AUM Growth
-$109M
Cap. Flow
-$155M
Cap. Flow %
-19.9%
Top 10 Hldgs %
99.62%
Holding
13
New
–
Increased
1
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$28.6M

Top Sells

Rank Stock Value
1
GLD icon
SPDR Gold Trust
GLD
+$184M

Sector Composition

Rank Sector Weight
1 Miscellaneous 92.8%
2 Healthcare 7.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
State Street SPDR S&P 500 ETF Trust
SPY
$804B
$510M 65.36%
974,641
+57,500
+6% +$28.6M
INDA icon
2
iShares MSCI India ETF
INDA
$6.51B
$125M 16.04%
2,425,144
– –
GLD icon
3
SPDR Gold Trust
GLD
$147B
$88.9M 11.4%
432,271
-957,729
-69% -$184M
ORIC icon
4
Oric Pharmaceuticals
ORIC
$1.32B
$13.6M 1.74%
989,410
– –
FHTX icon
5
Foghorn Therapeutics
FHTX
$248M
$10.6M 1.35%
1,573,761
– –
ALEC icon
6
Alector
ALEC
$208M
$7.87M 1.01%
1,307,858
– –
RAPT
7
DELISTED
RAPT Therapeutics
RAPT
$5.91M 0.76%
82,237
– –
ME
8
DELISTED
23andMe Holding Co
ME
$5.45M 0.7%
512,156
– –
TNYA icon
9
Tenaya Therapeutics
TNYA
$149M
$5.31M 0.68%
1,015,705
– –
PMVP icon
10
PMV Pharmaceuticals
PMVP
$78M
$4.47M 0.57%
2,627,643
– –
NGM
11
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$1.58M 0.2%
992,168
– –
SRZN icon
12
Surrozen
SRZN
$200M
$1.38M 0.18%
87,696
– –
SRZNW
13
DELISTED
Surrozen Inc Warrant
SRZNW
$5.16K ﹤0.01%
170,833
– –

Similar funds

TAA
Turiya Advisors Asia Hong Kong $440M AUM 152.81% 1-Year Est. Return
RWA
Roberts Wealth Advisors Palo Alto, California $440M AUM 26.51% 1-Year Est. Return
DSA
Droms Strauss Advisors St. Louis, Missouri $441M AUM 25.07% 1-Year Est. Return
AFP
Advus Financial Partners Winter Park, Florida $441M AUM 26.99% 1-Year Est. Return
NCM
New Capital Management Houston, Texas $439M AUM 16.55% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $439M AUM 52.19% 1-Year Est. Return
LWM
Long Walk Management Greenwich, Connecticut $441M AUM 30.08% 1-Year Est. Return
CSWG
Cardinal Strategic Wealth Guidance Louisville, Kentucky $441M AUM 25.22% 1-Year Est. Return

Euclidean Capital's Q1 2024 Portfolio in Review

As of Q1 2024, Euclidean Capital held 13 positions worth $780M, down 12% from $889M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Euclidean Capital withdrew a net $155M in Q1 2024, reducing 1 holding. Its largest reduction was SPDR Gold Trust, cutting an estimated $184M.

By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, up from 92% a quarter earlier, followed by Healthcare.

Against the trend, Euclidean Capital added an estimated $28.6M to State Street SPDR S&P 500 ETF Trust.

  • Euclidean Capital added most to State Street SPDR S&P 500 ETF Trust in Q1 2024, an estimated $28.6M increase.
  • Euclidean Capital's biggest Q1 2024 reduction was SPDR Gold Trust, cutting an estimated $184M.
  • Euclidean Capital's ten largest holdings make up 100% of its $780M portfolio in Q1 2024.
  • Euclidean Capital opened 0 new positions and closed 0 in Q1 2024.
  • Euclidean Capital's portfolio value fell 12% quarter-over-quarter to $780M.

Based on Euclidean Capital's 13F filing for Q1 2024, filed 15 May 2024.